About us Contacts Drug interactions: 390 212
Drug search by name

Carboplatin and Coumadin Injection

Determining the interaction of Carboplatin and Coumadin Injection and the possibility of their joint administration.

Check result:
Carboplatin <> Coumadin Injection
Relevance: 18.11.2023 Reviewer: Shkutko P.M., M.D., in

In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.

Consumer:

Using CARBOplatin together with warfarin can cause you to bleed more easily. You may need a dose adjustment in addition to testing of your prothrombin time or International Normalized Ratio (INR). Call your doctor promptly if you have any unusual bleeding or bruising, vomiting, blood in your urine or stools, headache, dizziness, or weakness. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Professional:

MONITOR: The combination of etoposide and carboplatin has been reported to potentiate the hypoprothrombinemic effect of warfarin in a patient stabilized on the anticoagulant. The patient presented 16 days after initiation of chemotherapy with suspected gastrointestinal bleeding and an INR of 12.6, compared to a baseline range of 1.15 to 2.11 over the previous 8 months. The exact mechanism of the interaction is unknown but may be related to protein binding displacement of warfarin. Etoposide is highly protein-bound in the plasma and has previously been reported to cause an increase in the INR within 24 hours of administration that lasted for approximately 3 days, consistent with the drug's relatively short half-life. The intermediate active platinum derived from carboplatin also binds to plasma proteins and has an elimination half-life of 4.9 to 5.8 days, which the investigators suggest may account for the delayed nature of the interaction in the reported case.

MANAGEMENT: Based on these observations, appropriate monitoring for excessive hypoprothrombinemia is recommended early on and later in time course following the addition of etoposide and carboplatin to a stabilized regimen of warfarin. The same precaution may be applicable during therapy with other oral anticoagulants, since these agents are all highly protein-bound in the plasma. Patients should be advised to promptly report any signs of bleeding to their physician, including pain, swelling, headache, dizziness, weakness, prolonged bleeding from cuts, increased menstrual flow, vaginal bleeding, nosebleeds, bleeding of gums from brushing, unusual bleeding or bruising, red or brown urine, or red or black stools.

References
  • Seifter EJ, Brooks BJ, Urba WJ "Possible interactions between warfarin and antineoplastic drugs." Cancer Treat Rep 69 (1985): 244-5
  • Le AT, Hasson NK, Lum BL "Enhancement of warfarin response in a patient receiving etoposide and carboplatin chemotherapy." Ann Pharmacother 31 (1997): 1006-8
Carboplatin

Generic Name: carboplatin

Brand name: Paraplatin, CARBOplatin Novaplus

Synonyms: CARBOplatin

Coumadin Injection

Generic Name: warfarin

Brand name: Coumadin, Jantoven

Synonyms: Coumadin

In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.

Interaction with food and lifestyle
Disease interaction